Welcome to LookChem.com Sign In|Join Free

CAS

  • or

16064-13-4

Post Buying Request

16064-13-4 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

16064-13-4 Usage

Check Digit Verification of cas no

The CAS Registry Mumber 16064-13-4 includes 8 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 5 digits, 1,6,0,6 and 4 respectively; the second part has 2 digits, 1 and 3 respectively.
Calculate Digit Verification of CAS Registry Number 16064-13:
(7*1)+(6*6)+(5*0)+(4*6)+(3*4)+(2*1)+(1*3)=84
84 % 10 = 4
So 16064-13-4 is a valid CAS Registry Number.

16064-13-4SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 17, 2017

Revision Date: Aug 17, 2017

1.Identification

1.1 GHS Product identifier

Product name 3-methyl-6-nitroquinazolin-4-one

1.2 Other means of identification

Product number -
Other names 3-Methyl-6-nitro-3H-chinazolin-4-on

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:16064-13-4 SDS

16064-13-4Relevant articles and documents

Synthesis and Cytotoxicity of Quinazolin-4(3H)-one Based Peptides

Bhavani, A. K. D.,Kumar, A. Kishore,Ramakrishna, K.,Shankaraiah, P.

, p. 720 - 724 (2020)

Abstract: A novel series of quinazolin-4(3H)-one derivatives has been synthesized in high yields using the multicomponent Ugi reaction and characterized by IR, NMR and mass spectral data. The products have been tested for their cytotoxic activity against HeLa cells. Two tested compounds have shown potent activity compared to standard drug Doxorubicin. The in silico docking studies of the compounds against quinone reductase-2 (4ZVM) enzyme have also supported their activity.

NEW BRAF INHIBITORS AS PARADOX BREAKERS

-

Page/Page column 40, (2021/06/22)

The invention provides a novel compound having the general formula (I) (I) wherein R1-R3 and X are as defined in the description and in the claims. The compound of formula (I) can be used as a medicament.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 16064-13-4